The Secondary Prevention of Coronary Artery Disease (Q41526401)

2 October 2017

1 reference

title

The secondary prevention of coronary artery disease (English)

1 reference

2 October 2017

The Secondary Prevention of Coronary Artery Disease (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

13 September 2024

author name string

C. N. Merz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9217673

13 September 2024

A. Rozanski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9217673

13 September 2024

J. S. Forrester

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9217673

13 September 2024

language of work or name

English

0 references

publication date

1 June 1997

1 reference

full work available at URL

2 October 2017

https://api.elsevier.com/content/article/PII:S0002934397000466?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

https://api.elsevier.com/content/article/PII:S0002934397000466?httpAccept=text/plain

13 September 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

American Journal of Medicine

13 September 2024

published in

1 reference

2 October 2017

volume

102

1 reference

2 October 2017

issue

6

1 reference

2 October 2017

page(s)

572-581

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

2 October 2017

1 reference

Prevention of coronary artery disease. A medical imperative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Cost containment in medicine: why cardiology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Ten-year incidence of myocardial infarction and prognosis after infarction. Department of Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Clinical implications of late proven patency after successful coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Controlled trial of clofibrate in cerebral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The Oslo diet-heart study. Eleven-year report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

CORN OIL IN TREATMENT OF ISCHAEMIC HEART DISEASE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Coronary heart disease: seven dietary factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Results of rehabilitation in coronary patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of cardiac rehabilitation after myocardial infarction: changes in coronary risk factors and long-term prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after myocardial infarction. The National Exercise and Heart Disease Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Relation of exercise to the recurrence rate of myocardial infarction in men. Ontario Exercise-Heart Collaborative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Long-term follow-up after a controlled randomized post-myocardial infarction rehabilitation programme: effects on morbidity and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Home versus group exercise training for increasing functional capacity after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Cardiac rehabilitation after acute myocardial infarction. 9-year controlled follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

5-year results of a comprehensive rehabilitation programme after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The National Exercise and Heart Disease Project: Long-term psychosocial outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

An overview of randomized trials of rehabilitation with exercise after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Exercise and human collateralization: an angiographic and scintigraphic assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of exercise training on left ventricular performance and myocardial perfusion in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Changes in rest and exercise myocardial perfusion and left ventricular function 3 to 26 weeks after clinically uncomplicated acute myocardial infarction: effects of exercise training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Myocardial perfusion changes following 1 year of exercise training assessed by thallium-201 circumferential count profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Low-fat diet and regular, supervised physical exercise in patients with symptomatic coronary artery disease: reduction of stress-induced myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of daily high-intensity exercise on myocardial perfusion in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Changes in Myocardial Perfusion Abnormalities by Positron Emission Tomography After Long-term, Intense Risk Factor Modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of a multidimensional cardiopulmonary rehabilitation program on psychosocial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of cardiac rehabilitation after coronary artery bypass grafting on readmissions, return to work, and physical fitness. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Relationship of β-adrenoreceptor density to fitness in athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

A randomised controlled trial of anti-smoking advice: 10-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Smoking and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Hypotensive therapy in stroke survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Blood pressure, stroke, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Morbidity, Mortality, and Antihypertensive Treatment Effects by Extent of Atherosclerosis in Older Adults With Isolated Systolic Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Diuretics, β-Blockers, and the Risk for Sudden Cardiac Death in Hypertensive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The Effects on Plasma Lipoproteins of a Prudent Weight-Reducing Diet, with or without Exercise, in Overweight Men and Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Management after myocardial infarction: a controlled trial of the effect of group psychotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Brief Group Therapy in Myocardial Infarction Rehabilitation: Three- to Four-Year Follow-Up of a Controlled Trial*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The ischemic heart disease life stress monitoring program: impact on mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

A note on behavioural treatment in the rehabilitation of myocardial infarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effects of Stress Management Training and Dietary Changes in Treating Ischemic Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Alteration of type A behavior and reduction in cardiac recurrences in postmyocardial infarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Psychologic treatment for the type A behavior pattern and for coronary heart disease: a meta-analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Long-term follow-up of the Ischemic Heart Disease Life Stress Monitoring Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Mental Stress and the Induction of Silent Myocardial Ischemia in Patients with Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Psychological distress as a predictor of ventricular arrhythmias in a post-myocardial infarction population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Cardiovascular reactivity and mental stress-induced myocardial ischemia in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Platelet activation and secretion associated with emotional stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 4. Efficacy of risk factor management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900046-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Controlled trial of soya-bean oil in myocardial infarction

11

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

Low fat, low cholesterol diet in secondary prevention of coronary heart disease

13 September 2024

43

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

Physical fitness and feasibility of physical rehabilitation after myocardial infarction in men of working age

13 September 2024

51

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

Exercise after myocardial infarction: a controlled trial

13 September 2024

56

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

13 September 2024

113

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

Effects of brief psychotherapy during the hospitalization period on the recovery process in heart attacks

13 September 2024

120

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

Group education after myocardial infarction: Is it effective?

13 September 2024

124

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

Mechanisms of behaviorally induced arrhythmias

13 September 2024

135

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00046-6

13 September 2024

Identifiers

1 reference

2 October 2017

1 reference